Biallelic loss of TRAPPC9 function links vesicle trafficking pathway to autosomal recessive intellectual disability

被引:11
|
作者
Aslanger, Ayca Dilruba [1 ]
Goncu, Beyza [2 ,3 ]
Duzenli, Omer Faruk [2 ]
Yucesan, Emrah [4 ]
Sengenc, Esma [5 ]
Yesil, Gozde [1 ]
机构
[1] Istanbul Univ, Fac Med, Dept Med Genet, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Expt Res Ctr, Istanbul, Turkey
[3] Bezmialem Vakif Univ, Vocat Sch Hlth Serv, Dept Med Serv & Tech, Istanbul, Turkey
[4] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[5] Bezmialem Vakif Univ, Fac Med, Dept Pediat Neurol, Istanbul, Turkey
关键词
BETA-BINDING PROTEIN; MUTATION; IDENTIFICATION; NIBP; NIK;
D O I
10.1038/s10038-021-01007-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background The trafficking protein particle (TRAPP) complex subunit 9 (C9) protein is a member of TRAPP-II complexes and regulates vesicle trafficking. Biallelic mutations in the TRAPPC9 gene are responsible for intellectual disability with expanded developmental delay, epilepsy, microcephaly, and brain atrophy. TRAPPC9-related disease list is still expanding, however, the functional effects of only a limited fraction of these have been studied. Methods In a patient with a pathological variant in TRAPPC9, clinical examination and cranial imaging findings were evaluated. Whole-exome sequencing, followed by Sanger sequencing was performed to detect and verify the variant. To confirm the functional effect of the mutation; variant mRNA and protein expression levels were evaluated by qRT-PCR and Western blotting. Immunostaining for TRAPPC9 and lipid droplet accumulation were examined. Results We have identified a novel homozygous c.696C>G (p.Phe232Leu) pathogenic variant in TRAPPC9 (NM_031466.6) gene as a cause of severe developmental delay. Functional characterization of the TRAPPC9 variant resulted in decreased mRNA and protein expression. The intracellular findings showed that TRAPPC9 protein build-up around the nucleus in mutant type while there was no specific accumulation in the control cell line. This disrupted protein pattern affected the amount of neutral lipid-carrying vesicles and their homogenous distribution at a decreasing level. Conclusion Biallelic variants in the TRAPPC9 gene have been reported as the underlying cause of intellectual disability. This study provides functional evidence of the novel variant in TRAPPC9 We demonstrated that the loss of function variant exclusively targeting TRAPPC9 may explicate the neurological findings through vesicle trafficking.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 50 条
  • [31] Further insights into the spectrum phenotype of TRAPPC9 and CDK5RAP2 genes, segregating independently in a large Tunisian family with intellectual disability and microcephaly
    Ben Ayed, Ikhlas
    Bouchaala, Wafa
    Bouzid, Amal
    Feki, Wiem
    Souissi, Amal
    Ben Nsir, Sihem
    Ben Said, Mariem
    Sammouda, Takwa
    Majdoub, Fatma
    Kharrat, Ines
    Kamoun, Fatma
    Elloumi, Ines
    Kamoun, Hassen
    Tlili, Abdelaziz
    Masmoudi, Saber
    Triki, Chahnez
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2021, 64 (12)
  • [32] SPATA5 mutations cause a distinct autosomal recessive phenotype of intellectual disability, hypotonia and hearing loss
    Buchert, Rebecca
    Nesbitt, Addie I.
    Tawamie, Hasan
    Krantz, Ian D.
    Medne, Livija
    Helbig, Ingo
    Matalon, Dena R.
    Reis, Andre
    Santani, Avni
    Sticht, Heinrich
    Abou Jamra, Rami
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [33] SPATA5 mutations cause a distinct autosomal recessive phenotype of intellectual disability, hypotonia and hearing loss
    Rebecca Buchert
    Addie I. Nesbitt
    Hasan Tawamie
    Ian D. Krantz
    Livija Medne
    Ingo Helbig
    Dena R. Matalon
    André Reis
    Avni Santani
    Heinrich Sticht
    Rami Abou Jamra
    Orphanet Journal of Rare Diseases, 11
  • [34] Autosomal Recessive Inflammatory Skin Disease Caused by a Novel Biallelic Loss-of-Function Variant in CARD11
    Amie Nguyen
    Henry Y. Lu
    Stuart E. Turvey
    Andrew L. Snow
    Journal of Clinical Immunology, 2023, 43 : 709 - 713
  • [35] A biallelic loss-of-function variant in TMEM147 causes profound intellectual disability and spasticity
    Tahereh Ghorashi
    Hossein Darvish
    Somayeh Bakhtiari
    Abbas Tafakhori
    Michael C. Kruer
    Hossein Mozdarani
    neurogenetics, 2023, 24 : 311 - 316
  • [36] A biallelic loss-of-function variant in TMEM147 causes profound intellectual disability and spasticity
    Ghorashi, Tahereh
    Darvish, Hossein
    Bakhtiari, Somayeh
    Tafakhori, Abbas
    Kruer, Michael C.
    Mozdarani, Hossein
    NEUROGENETICS, 2023, 24 (04) : 311 - 316
  • [37] Autosomal Recessive Inflammatory Skin Disease Caused by a Novel Biallelic Loss-of-Function Variant in CARD11
    Nguyen, Amie L.
    Lu, Henry E.
    Turvey, Stuart E.
    Snow, Andrew
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (04) : 709 - 713
  • [38] Biallelic UBE4A loss-of-function variants cause intellectual disability and global developmental delay
    Melo, Uira Souto
    Bonner, Devon
    Kent Lloyd, Kevin C.
    Moshiri, Ala
    Willis, Brandon
    Lanoue, Louise
    Bower, Lynette
    Leonard, Brian C.
    Martins, Davi Jardim
    Gomes, Fernando
    de Souza Leite, Felipe
    Oliveira, Danyllo
    Kitajima, Joao Paulo
    Monteiro, Fabiola P.
    Zatz, Mayana
    Menck, Carlos Frederico Martins
    Wheeler, Matthew T.
    Bernstein, Jonathan A.
    Dumas, Kevin
    Spiteri, Elizabeth
    Di Donato, Nataliya
    Jahn, Arne
    Hashem, Mais
    Alsaif, Hessa S.
    Chedrawi, Aziza
    Alkuraya, Fowzan S.
    Kok, Fernando
    Byers, Heather M.
    GENETICS IN MEDICINE, 2021, 23 (04) : 661 - 668
  • [39] Biallelic loss-of-function variants in DOCK3 cause muscle hypotonia, ataxia, and intellectual disability
    Helbig, K. L.
    Mroske, C.
    Moorthy, D.
    Sajan, S. A.
    Velinov, M.
    CLINICAL GENETICS, 2017, 92 (04) : 430 - 433
  • [40] New evidence that biallelic loss of function in EEF1B2 gene leads to intellectual disability
    Larcher, Lise
    Buratti, Julien
    Heron-Longe, Benedicte
    Benzacken, Brigitte
    Pipiras, Eva
    Keren, Boris
    Delahaye-Duriez, Andree
    CLINICAL GENETICS, 2020, 97 (04) : 639 - 643